Dolby Laboratories, Inc. — Fiscal 2020 Second-Quarter 10-Q
Reporting period: The 13-week fiscal quarter ended March 27, 2020; year-to-date figures cover the first six months of fiscal 2020. Financial amounts below are in U.S. dollars.
Business context and results
Dolby develops and licenses audio, imaging, and communications technologies, with licensing accounting for most revenue. It also sells products and services, including cinema equipment and conferencing solutions. The company reports as one operating segment.
| Metric | Q2 FY2020 | Q2 FY2019 | Six months FY2020 | Six months FY2019 |
|---|---|---|---|---|
| Revenue | $351.8m | $338.3m | $643.7m | $640.6m |
| Licensing revenue | $328.9m | $310.3m | $586.5m | $570.6m |
| Products and services revenue | $23.0m | $28.0m | $57.1m | $70.0m |
| Gross margin | $315.0m | $301.7m | $569.5m | $565.4m |
| Operating income | $105.9m | $102.9m | $154.5m | $171.6m |
| Net income attributable to Dolby | $88.5m | $73.4m | $137.2m | $171.7m |
| Diluted EPS | $0.86 | $0.70 | $1.33 | $1.63 |
Q2 revenue rose 4%, primarily on licensing growth; products and services fell 18%. Gross margin was approximately 89.5% of revenue, versus 89.2% a year earlier. Operating margin was approximately 30.1%, versus 30.4%. Q2 net income increased 20%, helped by a lower effective tax rate: 20.0% versus 33.1%, including the absence of a prior-year Tax Act-related expense. For the six months, revenue was nearly flat, while operating income declined 10% and net income declined 20%; the prior-year period included tax items that make the comparison uneven.
Cash flow, liquidity and capital
- Six-month operating cash flow was $96.9m, down from $105.8m. Investing activities used $47.2m; financing activities used $116.5m. Cash, cash equivalents, and restricted cash declined $71.1m to $734.4m.
- At March 27, 2020, cash and cash equivalents were $724.9m, short- and long-term investments totaled $302.2m, and working capital was $1.152bn. Current assets were $1.460bn versus current liabilities of $307.3m.
- Total liabilities were $575.6m. The balance sheet shows no borrowings; lease liabilities were $81.8m following adoption of lease accounting. The filing does not present a separate debt balance.
- Dolby repurchased 1.45m shares for $101.7m in the first half and paid $44.3m in dividends. The quarterly dividend was $0.22 per share. Approximately $259m remained authorized for repurchases at quarter-end.
Material changes, outlook and risks
- COVID-19: The pandemic disrupted consumer-product supply chains and shipments, reduced consumer demand and customer-shipment royalties, and led exhibitors to suspend or reduce operations. A substantial majority of Dolby Cinema locations were temporarily closed, weakening box-office-linked revenue and demand for cinema products and services. Management expected effects to extend into fiscal 2021, but said the duration and scale were uncertain.
- Management stated that available liquidity and operating cash flows should meet anticipated cash needs for at least the next 12 months, despite COVID-19 uncertainty. The filing provides no quantified revenue, earnings, or EPS guidance.
- Q2 licensing revenue included an approximately $7m favorable adjustment for previously estimated royalties, mainly related to October–December shipments. Royalty estimates and subsequent true-ups can create quarterly volatility.
- Products and services gross margin turned negative in Q2, at $(0.6)m versus $7.4m, reflecting higher excess and obsolescence charges and lower manufacturing utilization, alongside reduced cinema activity.
- General and administrative expense rose 28% in Q2, attributed primarily to legal, professional and consulting costs, as well as employee compensation. The six-month increase was 15%.
- Other notable exposures include dependence on licensees’ product shipments and royalty reporting, competition and technology adoption, cinema recovery and exhibitor viability, international trade and IP enforcement, foreign exchange, and tax uncertainties. Gross unrecognized tax benefits were $111.5m; $73.1m would reduce the effective tax rate if recognized.
- Legal proceedings were described as ordinary-course matters not expected to have a material adverse impact, although the company cautioned that outcomes are uncertain and some potential losses cannot be estimated. Contractual commitments totaled $133.8m, including $101.9m in naming-rights payments.
Most important facts for investors to verify
- How quickly consumer shipments and royalty collections recover, and whether actual royalty reports materially differ from estimates.
- The duration of cinema closures, box-office recovery, and the financial condition of Dolby’s exhibitor partners.
- Whether the favorable $7m royalty adjustment and other recoveries recur, and how underlying licensing trends perform without them.
- Trends in products and services margins, inventory charges, manufacturing utilization, and elevated G&A costs.
- Liquidity and capital-return decisions if pandemic-related cash flows weaken; dividend and repurchase plans remain subject to Board discretion.